WARMINSTER, Pa., Nov. 26, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: ABUS), (“Arbutus” or the “Company”), a clinical-stage ...

H.C. Wainwright initiated coverage of Redwire (RDW) with a Buy rating and $18 price target Redwire is positioned to be key beneficiary of ...

H.C. Wainwright adjusted the firm’s price target on Arqit Quantum (ARQQ) to $22 from $2 and keeps a Buy rating on the shares to reflect the ...

H.C. Wainwright analyst Andrew Fein lowered the firm’s price target on Alector (ALEC) to $7 from $35 and keeps a Buy rating ...

H.C. Wainwright has recently reduced Eyenovia Inc (EYEN) stock to Neutral rating, as announced on November 18, 2024, according to Finviz. Earlier, on March 1, 2021, Northland Capital had initiated the ...

On Tuesday, Cassava Sciences Inc (SAVA) stock saw a decline, ending the day at $3.83 which represents a decrease of $-0.47 or -10.93% from the prior close of $4.3. The stock opened at $4.32 and ...

Bionomics Limited, an Australia-based company listed on the OTCMKTS under the symbol BNOEF, recently disclosed in an 8-K filing with the Securities and Exchange Commission that it has entered into an ...

H.C. Wainwright analyst Yi Chen lowered the firm’s price target on Regenxbio (RGNX) to $36 from $40 and keeps a Buy rating on the shares after the ...

We recently compiled a list of the 15 AI News That Should Not Be Ignored. In this article, we are going to take a look at ...

H.C. Wainwright lowered the firm’s price target on Lexicon (LXRX) to $4 from $6 and keeps a Buy rating on the shares. The company announced that following a “deficiencies preclude discussion ...

H.C. Wainwright says Pyxis Oncology (PYXS) reported positive preliminary data from the ongoing Phase 1 study of PYX-201, an extra domain B splice variant of fibronectin targeted antibody-drug ...

On Wednesday, H.C. Wainwright reaffirmed its Buy rating and $40.00 stock price target for GH Research PLC (NASDAQ:GHRS), following the company's third-quarter financial results and corporate update.